|
End-of-day quote
Thailand S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 0.2900 THB | 0.00% |
|
+3.57% | -42.00% |
Company Valuation: Health Empire Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 254.2 | 2,988 | 1,668 | 745.3 | 236.7 | 211.3 |
| Change | - | 1,075.33% | -44.18% | -55.31% | -68.24% | -10.71% |
| Enterprise Value (EV) 1 | 280.9 | 3,021 | 1,703 | 769.7 | 116.7 | 146.7 |
| Change | - | 975.56% | -43.62% | -54.82% | -84.84% | 25.71% |
| P/E | -8.96x | -39.5x | -3.43x | -2.81x | -0.48x | -5.5x |
| PBR | -11.6x | 2.45x | 1.75x | 1.07x | 0.85x | 0.89x |
| PEG | - | 0.9x | -0x | 0.1x | -0x | 0.1x |
| Capitalization / Revenue | 2.33x | 24x | 14.1x | 29.7x | 5.17x | 1.94x |
| EV / Revenue | 2.57x | 24.3x | 14.4x | 30.7x | 2.55x | 1.35x |
| EV / EBITDA | -12x | -65.6x | -28.6x | -14.9x | -3.9x | -46.7x |
| EV / EBIT | -10.4x | -50.5x | -21.1x | -12.6x | -2.93x | -9.06x |
| EV / FCF | -60.9x | -42.2x | -28x | -52.1x | -4.15x | -12.1x |
| FCF Yield | -1.64% | -2.37% | -3.57% | -1.92% | -24.1% | -8.28% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.3743 | -0.2126 | -1.271 | -0.6903 | -1.168 | -0.091 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 109.1 | 124.4 | 118 | 25.07 | 45.81 | 108.8 |
| EBITDA 1 | -23.38 | -46.03 | -59.52 | -51.69 | -29.9 | -3.144 |
| EBIT 1 | -26.94 | -59.8 | -80.92 | -61.28 | -39.77 | -16.19 |
| Net income 1 | -28.37 | -45.21 | -457.3 | -264.5 | -458.3 | -38.46 |
| Net Debt 1 | 26.68 | 33.3 | 35.7 | 24.32 | -120 | -64.67 |
| Reference price 2 | 3.3540 | 8.4000 | 4.3600 | 1.9400 | 0.5600 | 0.5000 |
| Nbr of stocks (in thousands) | 75,795 | 355,700 | 382,500 | 384,200 | 422,681 | 422,681 |
| Announcement Date | 2/25/21 | 2/28/22 | 2/28/23 | 2/22/24 | 2/28/25 | 3/2/26 |
1THB in Million2THB
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 4.83M | |
| 7.66x | 1.19x | 6.63x | 3.5% | 34.12B | |
| 19.5x | 1.79x | 11.95x | -.--% | 24.12B | |
| 16.43x | 2.12x | 10.22x | 2.41% | 11.99B | |
| 6.57x | 0.91x | 5.3x | 4.14% | 3.93B | |
| 19.93x | 2.69x | 10.24x | 4.37% | 2.43B | |
| 98.08x | 0.68x | 4.57x | -.--% | 1.01B | |
| 64.03x | 1.65x | 21.71x | -.--% | 638M | |
| 14.69x | 1.68x | 6.3x | -.--% | 471M | |
| 11.35x | 0.55x | 6.95x | 6.07% | 408M | |
| Average | 28.69x | 1.47x | 9.32x | 2.28% | 7.91B | |
| Weighted average by Cap. | 14.59x | 1.54x | 8.94x | 2.25% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VIBE Stock
- Valuation Health Empire Corporation
Select your edition
All financial news and data tailored to specific country editions
